BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16137512)

  • 1. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD?
    Dobrzycki S; Baniukiewicz A; Korecki J; Bachórzewska-Gajewska H; Prokopczuk P; Musial WJ; Kamiński KA; Dabrowski A
    Int J Cardiol; 2005 Sep; 104(1):67-72. PubMed ID: 16137512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ischemic heart disease and gastro-oesophageal reflux disease--simultaneous 24 monitoring of ECG and oesophageal pH].
    Dobrzycki S; Baniukiewicz A; Musiał WJ; Skrodzka D; Zaremba-Woroniecka A; Korecki J; Łaszewicz W; Kralisz P; Paruk J; Kochman W
    Przegl Lek; 2002; 59(9):675-7. PubMed ID: 12632883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between gastroesophageal reflux disease and myocardial ischemia. Effect of reflux on temporary activity of autonomic nervous system.
    Dobrzycki S; Skrodzka D; Musiał WJ; Go M; Korecki J; Gugała K; Kralisz P; Prokopczuk P; Bachórzewska-Gajewska H; Kamiński K
    Rocz Akad Med Bialymst; 2004; 49():93-7. PubMed ID: 15631321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The course of gastroesophageal reflux disease in elderly patients with concomitant ischemic heart disease].
    Zvenigorodskaia LA; Taranchenko IuV
    Ter Arkh; 2006; 78(2):42-5. PubMed ID: 16613096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sleep disorders in patients with gastroesophageal reflux disease: an open clinical and pH metric prospective study].
    Karoui S; Chtara O; Bibani N; Kallel L; Zouiten L; Matri S; Serghini M; Boubaker J; Filali A
    Tunis Med; 2010 Mar; 88(3):172-7. PubMed ID: 20415190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
    Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
    Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of gastro-oesophageal reflux and oesophagocardiac reflex in patients with angina-like chest pain following cardiologic investigations.
    Rosztóczy A; Vass A; Izbéki F; Nemes A; Rudas L; Csanády M; Lonovics J; Forster T; Wittmann T
    Int J Cardiol; 2007 May; 118(1):62-8. PubMed ID: 16891012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
    Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
    Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of esophageal pH monitoring in symptomatic patients on PPI therapy.
    Charbel S; Khandwala F; Vaezi MF
    Am J Gastroenterol; 2005 Feb; 100(2):283-9. PubMed ID: 15667483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux.
    Ferrari M; Benini L; Brotto E; Locatelli F; De Iorio F; Bonella F; Tacchella N; Corradini G; Lo Cascio V; Vantini I
    Scand J Gastroenterol; 2007 Mar; 42(3):299-307. PubMed ID: 17354108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
    Xue Y; Zhou LY; Lin SR
    Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the acidity index and integrated intragastric acidity in 645 patients presenting with gastroesophageal reflux disease symptoms.
    Blonski WC; Shih GL; Brensinger CM; Katzka DA; Metz DC
    Scand J Gastroenterol; 2006 Apr; 41(4):382-9. PubMed ID: 16635904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of gastroesophageal reflux disease in elderly subjects using 24-hour esophageal pH monitoring.
    Wu B; Wang M; Li Y
    Chin Med J (Engl); 1999 Apr; 112(4):333-5. PubMed ID: 11593533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.